ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and DeathMark T. Vander Lugt, Sophie Paczesny, Qing Zhang et al.|New England Journal of Medicine|2013Cited by 403
Histologic and Immunohistologic Characterization of Skin Localization of Myeloid DisordersClaire Bénet, Tony Petrella, Aurélie Gomez et al.|American Journal of Clinical Pathology|2011Cited by 87
Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host diseaseWei Li, Sophie Paczesny, Liangyi Liu et al.|JCI Insight|2016Cited by 47